The main finding in our study was the significant correlation noted between CD44 rs187115 and the severity of HCC, where patients with at least one C allele at CD44 rs187115 were more likely to develop advanced HCC compared to wild-type (TT) carriers. Here, CD44 is linked to hepatocellular carcinoma.